agilon health (NYSE:AGL – Free Report) had its price objective hoisted by Truist Financial from $6.40 to $6.50 in a report released on Friday morning, Benzinga reports. The brokerage currently has a hold rating on the stock. Several other equities research analysts have also recently commented on the company. Barclays assumed coverage on agilon health […]